Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.
Aliment Pharmacol Ther
; 44(4): 400-10, 2016 08.
Article
in En
| MEDLINE
| ID: mdl-27291852
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Hepatitis C, Chronic
Type of study:
Evaluation_studies
/
Observational_studies
/
Prognostic_studies
Limits:
Aged80
Language:
En
Journal:
Aliment Pharmacol Ther
Journal subject:
FARMACOLOGIA
/
GASTROENTEROLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2016
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom